- spleen hypoplasia / MGI
- abnormal humoral immune response / MGI
- arrested B cell differentiation / MGI
- decreased IgG level / MGI
- decreased IgM level / MGI
- abnormal B cell differentiation / MGI
- abnormal lymph organ size / MGI
- abnormal lymph node B cell domain morphology / MGI
- abnormal B cell physiology / MGI
- decreased immunoglobulin level / MGI
- increased length of allograft survival / MGI
- decreased spleen weight / MGI
- increased T cell number / MGI
- decreased B cell number / MGI
- decreased T cell proliferation / MGI
- decreased memory T cell number / MGI
- increased single-positive T cell number / MGI
- lymph node hypoplasia / MGI
- decreased follicular B cell number / MGI
- decreased marginal zone B cell number / MGI
- decreased transitional stage B cell number / MGI
- decreased mature B cell number / MGI
- increased immature B cell number / MGI
- abnormal leukocyte morphology / MGI
- impaired humoral immune response / MGI
C57BL/6N-Tnfsf13btm1.1Arte/Ieg
| Status | Available to order |
| EMMA ID | EM:05501 |
| Citation information | RRID:IMSR_EM:05501 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
| International strain name | C57BL/6N-Tnfsf13btm1.1Arte/Ieg |
| Alternative name | TNFSF13b KO cond |
| Strain type | Targeted Mutant Strains : Conditional mutation |
| Allele/Transgene symbol | Tnfsf13btm1.1Arte |
| Gene/Transgene symbol | Tnfsf13b |
Information from provider
| Provider | Helmholtz Zentrum Muenchen |
| Provider affiliation | Institute of Experimental Genetics, Helmholtz Zentrum Muenchen German Research Center for Environmental Health (GmbH) |
| Genetic information | The mouse Tnfsf13b ORF is encoded by exons 1-7, with the TNF domain encoded by exons 4-7, while mouse exon 3 is not present in the human orthologue. Exons 5-6 have been flanked by loxP sites, as their genetic ablation should result in loss of function by deletion of more than 60% of the TNF domain. The conditional targeted mutation has been obtained by in vivo, flp recombinase-mediated removal of the neomycin selection marker. |
| Phenotypic information | TO BE PROVIDED |
| Breeding history | Targeting performed in C57BL/6N ES cells and confirmed by Southern blotting. Crossed to C57BL/6N-Tg(CAG-flpe)2Arte mice to obtain mutant founders with excised neo cassette. Maintained on C57BL/6N background. |
| References | None available |
| Homozygous fertile | not known |
| Homozygous viable | not known |
| Homozygous matings required | not known |
| Immunocompromised | not known |
Information from EMMA
| Archiving centre | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany |
| Animals used for archiving | heterozygous C57BL/6NTac males, wild-type C57BL/6N females |
| Stage of embryos | 2-cell |
Disease and phenotype information
MGI phenotypes (gene matching)
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).
